Issue 5/2016
Content (9 Articles)
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
Miriam G. Mooij, Anne T. Nies, Catherijne A. J. Knibbe, Elke Schaeffeler, Dick Tibboel, Matthias Schwab, Saskia N. de Wildt
Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I
Jeannine S. McCune, Meagan J. Bemer
Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II
Jeannine S. McCune, Meagan J. Bemer, Janel Long-Boyle
Effects of Age, Sex, and Race on the Safety and Pharmacokinetics of Single and Multiple Doses of Azilsartan Medoxomil in Healthy Subjects
Robert E. Harrell, Aziz Karim, Wencan Zhang, Caroline Dudkowski
Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir
Erik Mogalian, Polina German, Brian P. Kearney, Cheng Yong Yang, Diana Brainard, John McNally, Lisa Moorehead, Anita Mathias
Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat in Healthy Young Chinese Male Non-Smokers and Smokers: Results of a Randomized, Double-Blind, Placebo-Controlled Study
Xia Zhao, Zining Wang, Yukun Wang, Hong Zhang, Hartmut Blode, Kenichi Yoshikawa, Corina Becker, Sigrun Unger, Reiner Frey, Yimin Cui
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials
Jeanne S. Geiser, Michael A. Heathman, Xuewei Cui, Jennifer Martin, Corina Loghin, Jenny Y. Chien, Amparo de la Peña
Comment on: “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”
Henrique Horta Veloso
Author’s reply to Veloso HH Comment on “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”
Roger W. Jelliffe